vs
Dominari Holdings Inc.（DOMH）与帕可Bio（PACB）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是Dominari Holdings Inc.的1.5倍（$44.6M vs $30.1M），帕可Bio净利率更高（-90.4% vs -438.1%，领先347.7%），Dominari Holdings Inc.同比增速更快（220.4% vs 13.8%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
DOMH vs PACB — 直观对比
营收规模更大
PACB
是对方的1.5倍
$30.1M
营收增速更快
DOMH
高出206.6%
13.8%
净利率更高
PACB
高出347.7%
-438.1%
两年增速更快
DOMH
近两年复合增速
7.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $44.6M |
| 净利润 | $-131.8M | $-40.4M |
| 毛利率 | — | 37.1% |
| 营业利润率 | -8.9% | -92.3% |
| 净利率 | -438.1% | -90.4% |
| 营收同比 | 220.4% | 13.8% |
| 净利润同比 | -12426.2% | -1802.7% |
| 每股收益（稀释后） | $-6.94 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHPACB
| Q4 25 | $30.1M | $44.6M | ||
| Q3 25 | $50.8M | $38.4M | ||
| Q2 25 | $34.1M | $39.8M | ||
| Q1 25 | $8.1M | $37.2M | ||
| Q4 24 | $9.4M | $39.2M | ||
| Q3 24 | $4.0M | $40.0M | ||
| Q2 24 | $6.2M | $36.0M | ||
| Q1 24 | $1.4M | $38.8M |
净利润DOMHPACB
| Q4 25 | $-131.8M | $-40.4M | ||
| Q3 25 | $125.2M | $-38.0M | ||
| Q2 25 | $16.6M | $-41.9M | ||
| Q1 25 | $-32.5M | $-426.1M | ||
| Q4 24 | $1.1M | $2.4M | ||
| Q3 24 | $-4.2M | $-60.7M | ||
| Q2 24 | $-6.1M | $-173.3M | ||
| Q1 24 | $-5.4M | $-78.2M |
毛利率DOMHPACB
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 41.4% | ||
| Q2 25 | — | 36.9% | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 25.0% | ||
| Q2 24 | — | 16.5% | ||
| Q1 24 | — | 29.1% |
营业利润率DOMHPACB
| Q4 25 | -8.9% | -92.3% | ||
| Q3 25 | -3.1% | -101.1% | ||
| Q2 25 | -57.0% | -112.8% | ||
| Q1 25 | -394.6% | -1154.5% | ||
| Q4 24 | 0.4% | -390.1% | ||
| Q3 24 | -79.1% | -160.3% | ||
| Q2 24 | -44.3% | -488.3% | ||
| Q1 24 | -205.2% | -209.6% |
净利率DOMHPACB
| Q4 25 | -438.1% | -90.4% | ||
| Q3 25 | 246.4% | -98.9% | ||
| Q2 25 | 48.7% | -105.4% | ||
| Q1 25 | -400.5% | -1146.8% | ||
| Q4 24 | 11.4% | 6.0% | ||
| Q3 24 | -104.2% | -151.9% | ||
| Q2 24 | -99.1% | -481.3% | ||
| Q1 24 | -398.0% | -201.4% |
每股收益（稀释后）DOMHPACB
| Q4 25 | $-6.94 | $-0.11 | ||
| Q3 25 | $7.27 | $-0.13 | ||
| Q2 25 | $1.12 | $-0.14 | ||
| Q1 25 | $-3.02 | $-1.44 | ||
| Q4 24 | $0.21 | $-0.44 | ||
| Q3 24 | $-0.67 | $-0.22 | ||
| Q2 24 | $-1.01 | $-0.64 | ||
| Q1 24 | $-0.91 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $279.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $5.3M |
| 总资产 | $112.9M | $784.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHPACB
| Q4 25 | $80.5M | $279.5M | ||
| Q3 25 | $176.2M | $298.7M | ||
| Q2 25 | $28.2M | $314.7M | ||
| Q1 25 | $18.9M | $343.1M | ||
| Q4 24 | $8.2M | $389.9M | ||
| Q3 24 | $7.2M | $471.1M | ||
| Q2 24 | $12.1M | $509.8M | ||
| Q1 24 | $7.1M | $561.9M |
股东权益DOMHPACB
| Q4 25 | $69.4M | $5.3M | ||
| Q3 25 | $210.2M | $36.1M | ||
| Q2 25 | $88.6M | $61.5M | ||
| Q1 25 | $42.4M | $91.6M | ||
| Q4 24 | $39.9M | $506.6M | ||
| Q3 24 | $38.3M | $453.1M | ||
| Q2 24 | $42.4M | $492.7M | ||
| Q1 24 | $47.7M | $649.0M |
总资产DOMHPACB
| Q4 25 | $112.9M | $784.1M | ||
| Q3 25 | $223.4M | $803.2M | ||
| Q2 25 | $109.3M | $825.5M | ||
| Q1 25 | $52.3M | $860.8M | ||
| Q4 24 | $47.1M | $1.3B | ||
| Q3 24 | $43.4M | $1.5B | ||
| Q2 24 | $49.1M | $1.5B | ||
| Q1 24 | $52.2M | $1.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.9M |
| 自由现金流率自由现金流/营收 | — | -44.6% |
| 资本支出强度资本支出/营收 | — | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-114.1M |
8季度趋势，按日历期对齐
经营现金流DOMHPACB
| Q4 25 | $22.7M | $-19.1M | ||
| Q3 25 | $-4.9M | $-18.7M | ||
| Q2 25 | $-353.0K | $-29.4M | ||
| Q1 25 | $1.2M | $-44.1M | ||
| Q4 24 | $-16.7M | $-30.6M | ||
| Q3 24 | $-4.7M | $-45.5M | ||
| Q2 24 | $1.4M | $-54.3M | ||
| Q1 24 | $-8.6M | $-75.7M |
自由现金流DOMHPACB
| Q4 25 | — | $-19.9M | ||
| Q3 25 | — | $-18.8M | ||
| Q2 25 | — | $-29.9M | ||
| Q1 25 | — | $-45.4M | ||
| Q4 24 | — | $-32.3M | ||
| Q3 24 | — | $-46.3M | ||
| Q2 24 | — | $-55.7M | ||
| Q1 24 | — | $-79.6M |
自由现金流率DOMHPACB
| Q4 25 | — | -44.6% | ||
| Q3 25 | — | -48.9% | ||
| Q2 25 | — | -75.3% | ||
| Q1 25 | — | -122.3% | ||
| Q4 24 | — | -82.3% | ||
| Q3 24 | — | -115.7% | ||
| Q2 24 | — | -154.8% | ||
| Q1 24 | — | -205.0% |
资本支出强度DOMHPACB
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 3.7% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 4.1% | ||
| Q1 24 | — | 10.0% |
现金转化率DOMHPACB
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | -12.93× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
